Question 1

What is the catalog number for CHO-K1/HEK293 Cells Stable expressing GPCR protein QRFPR (Protein accession # NM_198179)?

Accepted Answer

The catalog number for CHO-K1/HEK293 Cells Stable expressing GPCR protein QRFPR (Protein accession # NM_198179) is cAP-1372.

Question 2

What sizes are available for CHO-K1/HEK293 Cells Stable expressing GPCR protein QRFPR (Protein accession # NM_198179)?

Accepted Answer

CHO-K1/HEK293 Cells Stable expressing GPCR protein QRFPR (Protein accession # NM_198179) is available in the following size(s): 1 Frozen Vial.

Question 3

Is CHO-K1/HEK293 Cells Stable expressing GPCR protein QRFPR (Protein accession # NM_198179) in stock?

Accepted Answer

CHO-K1/HEK293 Cells Stable expressing GPCR protein QRFPR (Protein accession # NM_198179) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Question 5

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

Question 6

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

CHO-K1/HEK293 Cells Stable expressing GPCR protein QRFPR (Protein accession # NM_198179)

Product Specifications

Frequently Asked Questions

Explore Other Products

CD11b / MAC-1 (Microglial Marker) (ITGAM/3340), 1mg/mL

Anti-PCDH15 Antibody Picoband®, Dylight550 Conjugate

Anti-GAD65/GAD2 Antibody Picoband®, FITC Conjugate

Cytokeratin 8 (KRT8) (KRT8/2115), Biotin conjugate, 0.1mg/mL

Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), Biotin conjugate, 0.1mg/mL

Carcinoembryonic Antigen (CEA) / CD66 (C66/2055R), CF405S conjugate, 0.1mg/mL